[HTML][HTML] Estrogens, inflammation and cognition
A Au, A Feher, L McPhee, A Jessa, S Oh… - Frontiers in …, 2016 - Elsevier
The effects of estrogens are pleiotropic, affecting multiple bodily systems. Changes from the
body's natural fluctuating levels of estrogens, through surgical removal of the ovaries …
body's natural fluctuating levels of estrogens, through surgical removal of the ovaries …
Bio-psycho-socio-cultural perspectives on menopause
M Hunter, M Rendall - Best practice & research Clinical obstetrics & …, 2007 - Elsevier
The menopause transition is a bio-psycho-socio-cultural process. Recent prospective
studies highlight the complex ways in which lifestyle and cultural factors influence women's …
studies highlight the complex ways in which lifestyle and cultural factors influence women's …
Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized …
B Ayers, M Smith, J Hellier, E Mann, MS Hunter - Menopause, 2012 - journals.lww.com
Objective The aim of this study was to examine the effectiveness of group cognitive
behavioral therapy (CBT) and guided self-help CBT in reducing hot flush and night sweat …
behavioral therapy (CBT) and guided self-help CBT in reducing hot flush and night sweat …
Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9
DL Barton, BI LaVasseur, JA Sloan… - Journal of clinical …, 2010 - ascopubs.org
Purpose Up to 75% of women experience hot flashes, which can negatively impact quality of
life. As hot flash physiology is not definitively understood, it cannot be assumed that effective …
life. As hot flash physiology is not definitively understood, it cannot be assumed that effective …
The pollen extract Femal—a nonestrogenic alternative to hormone therapy in women with menopausal symptoms
AC Hellström, J Muntzing - Menopause, 2012 - journals.lww.com
Objective Hormone therapy with estrogen alone or combined with progestogen has come
into disrepute because of safety concerns. Herbal medicinal products with an estrogenic …
into disrepute because of safety concerns. Herbal medicinal products with an estrogenic …
Cognitive behavioural interventions for premenstrual and menopausal symptoms
M Hunter - Journal of reproductive and Infant Psychology, 2003 - Taylor & Francis
Bodily experiences and emotional changes occurring during the premenstrual phase of the
cycle, and hot flushes and night sweats occurring during the menopause, are not …
cycle, and hot flushes and night sweats occurring during the menopause, are not …
[HTML][HTML] A randomized controlled trial of relaxation training to reduce hot flashes in women with primary breast cancer
Hot flashes are experienced by about 52% of perimenopausal women. After breast cancer,
this may increase to 70%. The use of hormone replacement therapy is not recommended in …
this may increase to 70%. The use of hormone replacement therapy is not recommended in …
Efficacy of a biobehavioral intervention for hot flashes: a randomized controlled pilot study
DL Barton, KCF Schroeder, T Banerjee, S Wolf… - Menopause, 2017 - journals.lww.com
Objective: The need for effective nonhormonal treatments for hot flash management without
unwanted side effects continues. The primary aim of this pilot study was to evaluate the …
unwanted side effects continues. The primary aim of this pilot study was to evaluate the …
Non-hormonal management of vasomotor symptoms
J Sassarini, MA Lumsden - Climacteric, 2013 - Taylor & Francis
Vasomotor symptoms are the most common indication for the prescription of hormone
replacement therapy since it is effective in over 80% of cases. In 1995, 37% of American …
replacement therapy since it is effective in over 80% of cases. In 1995, 37% of American …
A randomised controlled trial of cognitive-behavioural therapy for women with problematic menopausal hot flushes: MENOS 2 trial protocol
B Ayers, E Mann, MS Hunter - BMJ open, 2011 - bmjopen.bmj.com
Objectives Hot flushes and night sweats (HF/NS) are experienced by 60–70% of
menopausal women and are problematic for approximately 20–25%. Potential health risks …
menopausal women and are problematic for approximately 20–25%. Potential health risks …